Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice.

McQuade RM, Carbone SE, Stojanovska V, Rahman A, Gwynne RM, Robinson AM, Goodman CA, Bornstein JC, Nurgali K.

Br J Pharmacol. 2016 Dec;173(24):3502-3521. doi: 10.1111/bph.13646. Epub 2016 Nov 16.

2.

Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms.

Goodman CA, Hornberger TA, Robling AG.

Bone. 2015 Nov;80:24-36. doi: 10.1016/j.bone.2015.04.014. Review.

3.

PGC-1α overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization.

Kang C, Goodman CA, Hornberger TA, Ji LL.

FASEB J. 2015 Oct;29(10):4092-106. doi: 10.1096/fj.14-266619. Epub 2015 Jul 15.

4.

Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content.

Goodman CA, Pol D, Zacharewicz E, Lee-Young RS, Snow RJ, Russell AP, McConell GK.

PLoS One. 2015 May 28;10(5):e0128398. doi: 10.1371/journal.pone.0128398. eCollection 2015.

5.

Yes-Associated Protein is up-regulated by mechanical overload and is sufficient to induce skeletal muscle hypertrophy.

Goodman CA, Dietz JM, Jacobs BL, McNally RM, You JS, Hornberger TA.

FEBS Lett. 2015 Jun 4;589(13):1491-7. doi: 10.1016/j.febslet.2015.04.047. Epub 2015 May 8.

6.

Prioritization of skeletal muscle growth for emergence from hibernation.

Hindle AG, Otis JP, Epperson LE, Hornberger TA, Goodman CA, Carey HV, Martin SL.

J Exp Biol. 2015 Jan 15;218(Pt 2):276-84. doi: 10.1242/jeb.109512. Epub 2014 Dec 1.

7.

Unaccustomed eccentric contractions impair plasma K+ regulation in the absence of changes in muscle Na+,K+-ATPase content.

Goodman CA, Bennie JA, Leikis MJ, McKenna MJ.

PLoS One. 2014 Jun 24;9(6):e101039. doi: 10.1371/journal.pone.0101039. eCollection 2014.

8.

New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass.

Goodman CA, Hornberger TA.

F1000Prime Rep. 2014 Apr 1;6:20. doi: 10.12703/P6-20. eCollection 2014. Review.

9.

The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy.

You JS, Lincoln HC, Kim CR, Frey JW, Goodman CA, Zhong XP, Hornberger TA.

J Biol Chem. 2014 Jan 17;289(3):1551-63. doi: 10.1074/jbc.M113.531392. Epub 2013 Dec 3.

10.

A role for Raptor phosphorylation in the mechanical activation of mTOR signaling.

Frey JW, Jacobs BL, Goodman CA, Hornberger TA.

Cell Signal. 2014 Feb;26(2):313-22. doi: 10.1016/j.cellsig.2013.11.009. Epub 2013 Nov 13.

11.

The mechanical activation of mTOR signaling: an emerging role for late endosome/lysosomal targeting.

Jacobs BL, Goodman CA, Hornberger TA.

J Muscle Res Cell Motil. 2014 Feb;35(1):11-21. doi: 10.1007/s10974-013-9367-4. Epub 2013 Oct 29. Review.

12.

Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.

Goodman CA, McNally RM, Hoffmann FM, Hornberger TA.

Mol Endocrinol. 2013 Nov;27(11):1946-57. doi: 10.1210/me.2013-1194. Epub 2013 Sep 3.

13.

Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania.

Njau JD, Kabanywanyi AM, Goodman CA, Macarthur JR, Kapella BK, Gimnig JE, Kahigwa E, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2013 Jul 11;12:236. doi: 10.1186/1475-2875-12-236.

14.

Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome.

Jacobs BL, You JS, Frey JW, Goodman CA, Gundermann DM, Hornberger TA.

J Physiol. 2013 Sep 15;591(18):4611-20. doi: 10.1113/jphysiol.2013.256339. Epub 2013 Jun 3.

15.

The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.

Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd JE, Snow RW, Goodman CA.

Malar J. 2013 Mar 1;12:81. doi: 10.1186/1475-2875-12-81.

16.

Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.

Kedenge SV, Kangwana BP, Waweru EW, Nyandigisi AJ, Pandit J, Brooker SJ, Snow RW, Goodman CA.

PLoS One. 2013;8(1):e54371. doi: 10.1371/journal.pone.0054371. Epub 2013 Jan 14.

17.

Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques?

Goodman CA, Hornberger TA.

Exerc Sport Sci Rev. 2013 Apr;41(2):107-15. doi: 10.1097/JES.0b013e3182798a95. Review.

18.

Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature.

Wafula FN, Miriti EM, Goodman CA.

BMC Health Serv Res. 2012 Jul 27;12:223. doi: 10.1186/1472-6963-12-223. Review.

19.

Muscle fiber type-dependent differences in the regulation of protein synthesis.

Goodman CA, Kotecki JA, Jacobs BL, Hornberger TA.

PLoS One. 2012;7(5):e37890. doi: 10.1371/journal.pone.0037890. Epub 2012 May 22.

20.

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.

Khatib RA, Skarbinski J, Njau JD, Goodman CA, Elling BF, Kahigwa E, Roberts JM, MacArthur JR, Gutman JR, Kabanywanyi AM, Smith EE, Somi MF, Lyimo T, Mwita A, Genton B, Tanner M, Mills A, Mshinda H, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140.

Supplemental Content

Loading ...
Support Center